Nrf2-Mediated Metabolic Reprogramming in Cancer

Yan-Yang Wang1,2, Juan Chen3, Xiao-Ming Liu4

  • 1Department of Radiation Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China.

Insights

The Nrf2 pathway regulates cancer metabolism, influencing tumor growth and treatment resistance. Understanding this link may lead to new cancer biomarkers and therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Metabolic reprogramming is a key feature of cancer.
  • The Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is crucial for cellular defense against oxidative stress.
  • Emerging evidence highlights the role of Nrf2 in cancer metabolism.

Purpose of the Study:

  • To review the role of Nrf2 in cancer metabolic reprogramming.
  • To highlight Nrf2's influence on malignant transformation, proliferation, and treatment resistance.
  • To discuss potential future applications in cancer diagnostics and therapeutics.

Main Methods:

  • Literature review of studies on Nrf2 and cancer metabolism.
  • Analysis of Nrf2-mediated metabolic pathways in cancer.
  • Synthesis of current knowledge on Nrf2's impact on cancer progression and therapy.

Main Results:

  • Nrf2 significantly impacts cancer cell metabolism.
  • Nrf2 activation promotes metabolic adaptations supporting cancer growth.
  • Nrf2 plays a role in developing resistance to cancer treatments.

Conclusions:

  • Nrf2-directed metabolic reprogramming is central to cancer development.
  • Targeting Nrf2 offers potential for novel cancer therapies.
  • Further research may yield noninvasive biomarkers for Nrf2-driven cancers.

Related Concept Videos

What is Metabolism?00:52

What is Metabolism?

Overview
132.4K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
111.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K